δ9-THC-d9 (CRM) (Synonyms: Δ9-Tetrahydrocannabinol-d9, Dronabinol-d9) |
| Katalog-Nr.GC49579 |
A Certified Reference Material
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: N/A
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
δ9-THC-d9 (CRM) is intended for use as an internal standard for the quantification of δ9-THC-d9 by GC- or LC-MS. δ9-THC-d9 is categorized as a cannabinoid.1,2 It is psychoactive and has diverse effects on perception, cognition, and pain sensitivity.3 δ9-THC-d9 is regulated as a Schedule I compound in the United States. δ9-THC-d9 (CRM) is provided as a DEA exempt preparation. This product is intended for research and forensic applications.
1.Huffman, J.W., Padgett, L.W., Isherwood, M.L., et al.1-Alkyl-2-aryl-4-(1-naphthoyl)pyrroles: New high affinity ligands for the cannabinoid CB1 and CB2 receptorsBioorg. Med. Chem. Lett.16(20)5432-5435(2006) 2.Pertwee, R.G.Pharmacology of cannabinoid receptor ligandsCurr. Med. Chem.6(8)635-664(1999) 3.Grotenhermen, F.Pharmacokinetics and pharmacodynamics of cannabinoidsClin. Pharmacokinet.42(4)327-360(2003)
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *